Average Co-Inventor Count = 5.12
ph-index = 26
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xencor, Inc. (171 from 216 patents)
2. Allergan, Inc. (3 from 2,285 patents)
3. Genentech, Inc. (1 from 3,212 patents)
4. Syngenta Participations Ag (1 from 1,777 patents)
5. Amgen Inc. (1,960 patents)
172 patents:
1. 12448423 - Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains
2. 12415849 - Heterodimeric proteins
3. 12404329 - Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
4. 12398207 - Heterodimeric antibodies that bind CD3 and CLDN6
5. 12378326 - Anti-CD28 x anti-PSMA antibodies
6. 12365743 - Anti-CD28 x anti-PSMA antibodies
7. 12359002 - Heterodimeric antibodies that bind CD3 and tumor antigens
8. 12239688 - IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof
9. 12234270 - IL-12 heterodimeric Fc-fusion proteins
10. 12215165 - Fc variants with altered binding to FcRn
11. 12180302 - Heterodimeric antibodies that bind fibroblast activation protein
12. 12152076 - Bispecific and monospecific antibodies using novel anti-PD-1 sequences
13. 12139525 - Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
14. 12129309 - Heterodimeric antibodies that bind CD3 and CD38
15. 11981717 - Engineered IL-2 Fc fusion proteins